Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories abbott India — Earnings Per Share (INR / Share)
Abbott India Limited Filings (NSE: ABBOTINDIA / Screener.in)
Latest, Q2 2026
202
Period ended Jun 30, 2026
Change on a year earlier
+17.1%
172 in Q2 2025
History
13 quarters
Since Q2 2023
Sources
1
Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in)
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Abbott Laboratories Abbott India — Earnings Per Share (INR / Share), quarterly Q2 2023–Q2 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/ind-eps
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.